THE BLUCANDO GROUP LIMITED

Executive Summary

THE BLUCANDO GROUP LIMITED is currently in a precarious financial position with negative net assets and heavy reliance on intra-group loans. The company’s survival depends on continued external support, highlighting the need for urgent measures to strengthen its capital base and improve liquidity. With targeted operational and financial interventions, the company can stabilize and work towards sustainable growth.

THE BLUCANDO GROUP LIMITED - Analysis Report

Company Number: 13526537

Analysis Date: 2025-07-20 18:47 UTC

Financial Health Assessment of THE BLUCANDO GROUP LIMITED

---

1. Financial Health Score: D

Explanation:
THE BLUCANDO GROUP LIMITED shows clear symptoms of financial distress with persistent negative net assets and negative working capital over multiple years. The company is reliant on director and creditor support to continue as a going concern. While the business remains operational (active status), its financial "vital signs" indicate vulnerability and a weakened financial position. This score reflects a critical need for intervention to restore financial health.

---

2. Key Vital Signs

Metric	Latest Value (2024)	Interpretation
Net Assets	£-3,794	Negative net assets indicate the company owes more than it owns, a key symptom of financial distress.
Net Current Assets	£-3,935	Negative working capital means current liabilities exceed current assets, risking liquidity problems.
Share Capital	£6	Very low share capital; the company has limited equity buffer against losses.
Investments (Fixed Assets)	£141	Minimal fixed assets, suggesting limited tangible or long-term investment base.
Trade Creditors	£27	Small portion of current liabilities; majority owed to group undertakings and other creditors.
Amounts owed to group	£2,955	Large intra-group debt signals reliance on related entities for financing.
Profit & Loss Account	£-3,800	Accumulated losses underline ongoing unprofitability or investment into the business.
Going Concern Note	Yes (dependent on support)	Directors acknowledge reliance on continued support from directors and creditors to remain operational.

---

3. Diagnosis: What the Financial Data Reveals

The company is exhibiting chronic financial symptoms often seen in early-stage or investment-heavy businesses struggling with cash flow and capital structure:

• Negative net assets and working capital: The company’s liabilities exceed assets by a significant margin, signaling financial strain and potential solvency concerns if external support wanes.
• Reliance on related party funding: Substantial amounts owed to group undertakings suggest the company depends on intra-group financing rather than operational cash generation.
• Minimal tangible assets: The low level of fixed assets indicates limited collateral or capital base, restricting borrowing capacity.
• Loss accumulation: The P&L reserve is deeply negative, suggesting the company has been funding losses or investing without generating corresponding profits.
• Going concern caution: Directors explicitly state the company’s survival hinges on ongoing financial support, highlighting vulnerability.

Overall, the company appears to be in a fragile financial state, with symptoms akin to a patient under stress who requires monitoring and treatment to prevent deterioration.

---

4. Recommendations: Steps to Improve Financial Wellness

1. Strengthen Capital Base

   • Consider a capital injection or equity raise to improve net assets and create a buffer for losses.
   • Explore options to convert intra-group loans to equity to reduce current liabilities.

2. Improve Liquidity Management

   • Develop a cash flow forecasting model to anticipate liquidity needs.
   • Negotiate extended payment terms with creditors where possible to reduce short-term cash demands.

3. Operational Review for Profitability

   • Conduct a detailed review of business operations to identify cost-saving opportunities and revenue growth strategies.
   • Evaluate pricing, customer mix, and service delivery efficiency to enhance margins.

4. Formalize Support Arrangements

   • Secure written agreements for director or group company support to provide clarity to stakeholders and improve creditworthiness.

5. Regular Financial Monitoring

   • Implement monthly financial reporting focusing on liquidity and working capital metrics.
   • Early identification of warning signs can enable timely management interventions.

6. Consider Professional Advice

   • Engage financial advisors or restructuring specialists to explore turnaround strategies or refinancing options.

---

Medical Analogy Summary

THE BLUCANDO GROUP LIMITED’s financial health can be likened to a patient with chronic illness: it shows persistent symptoms of distress (negative equity and cash flow challenges) but is currently stable due to external support (like a patient on medication). Without intervention (capital strengthening and operational improvements), the company risks "organ failure" (insolvency). Proactive "treatment" and monitoring are essential to restore vitality and long-term health.

---